Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
In the DSM-5 released in May, PTSD just got more complex. It added a new symptom domain of "negative alterations in cognitions or mood," and expanded the hyperarousal domain to include aggressive, ...
—Although those with subthreshold PTSD are at least 6 times as likely to develop PTSD relative to those with minimal or no symptoms, data are lacking on higher-risk populations, such as US veterans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results